Quantcast

Latest Nymox Pharmaceutical Corporation Stories

2014-05-14 08:26:33

NEW YORK, May 14, 2014 /PRNewswire/ -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) specializes in the research and development of therapeutics and diagnostics, with a particular emphasis

2008-11-12 12:00:07

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce positive new results from the Company's most recent study of NX-1207, its drug in development for benign prostatic hyperplasia (BPH). A total of 67 patients and controls in this multi-center U.S.

2008-10-30 12:00:21

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that data about the progress of Nymox's drug development for NX-1207, the Company's investigational drug for benign prostatic hyperplasia (BPH), were presented this morning at the 84th Annual Meeting of the Western Section of the American Urological Association being held in Monterey, CA.

2008-10-29 12:00:07

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD). The newly published results of a major long-term study (J Neurol NeuroSurg Psychiatry Oct.

2008-10-28 12:00:17

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that recent results of clinical studies of NX-1207, the Company's investigational drug for the treatment of benign prostatic hyperplasia (BPH) or enlarged prostate, will be presented this Thursday at the 84th Annual Meeting of the Western Section of the American Urological Association being held in Monterey, California.

2008-10-22 12:00:16

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company's latest multi-center U.S. study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH), is nearing completion.

2008-10-20 12:00:10

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease.

2008-10-10 12:00:42

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is please to announce that the presentation of NX-1207 clinical study data at the AUA South Central Section annual meeting in Santa Ana Pueblo, NM was featured in the Urology Times, the widely distributed and most read publication of U.S. urologists.

2008-10-08 12:00:08

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) provided today an update on development activities for the Company's NX-1207 drug for the treatment of benign prostatic hyperplasia (BPH) or enlarged prostate, a common affliction of older men.


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related